MANAL ABDELMALEK

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology DURHAM, NC NPI 1013964873

General Payments — all program years on this page

$317,976.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 185
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,897.47 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $14,531.253
Travel and Lodging $8,382.343
Honoraria $1,600.001
Food and Beverage $383.885

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $21,576.526
Madrigal Pharmaceuticals $1,720.803
Novo Nordisk AS $1,550.002
GlaxoSmithKline, LLC. $50.151

By program year

Program yearAmountRecords
2018 $28,606.3334
2019 $56,289.9050
2020 $44,640.1619
2021 $31,626.4412
2022 $60,863.2234
2023 $71,052.7724
2024 $24,897.4712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096552289 Novo Nordisk AS $50.00 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552403 Novo Nordisk AS $307.58 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552437 Novo Nordisk AS $162.93 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552499 Novo Nordisk AS $12,981.25 04/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096552627 Novo Nordisk AS $7,752.58 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096553031 Novo Nordisk AS $322.18 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096879471 Novo Nordisk Inc $387.50 11/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097602772 Novo Nordisk Inc $1,162.50 10/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116690789 GlaxoSmithKline, LLC. $50.15 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144159289 Madrigal Pharmaceuticals $1,600.00 11/14/2024 Honoraria Undisputed 01/23/2026 View at CMS
1144159291 Madrigal Pharmaceuticals $42.53 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144159293 Madrigal Pharmaceuticals $78.27 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.